Correspondence
A case of Churg-Strauss vasculitis after hepatitis B vaccination
| The first 150 words of the full text of this article appear below. |
Vaccination against hepatitis B with recombinant vaccine is highly effective in producing immunity in immunocompetent patients. It has few side effects, usually consisting of early local reactions to the thimerosal or aluminium components of the vaccine. Vasculitis have been reported after BCG inoculation and vaccination against flu, measles, and hepatitis B. For the latter, some cases have been described after inoculation of both plasma derived and recombinant vaccine: cryoglobulinaemia, pulmonary and cutaneous vasculitis, erythema nodosum, Takayasu's arteritis, and polyarteritis nodosa.1-9 We describe a case of Churg-Strauss vasculitis (CSv) developing after vaccination against hepatitis B with recombinant vaccine.
The patient's personal and family histories were negative for
autoimmune and allergic diseases; in particular, neither atopy nor
eczema were reported. The patient's available previous full blood
counts with differential counts were normal. At the age of 20, from
November 1989 to May 1990, using the recommended dosing and time
schedule, she had been vaccinated against HBV
This article has been cited by other articles:
-
SCOTT, D. G I, WATTS, R. A
(2000). Systemic vasculitis: epidemiology, classification and environmental factors. Ann Rheum Dis
59: 161-163
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
